Updates are available Correction dated 2021-02-06
Click to view Correction: https://doi.org/10.1007/s10067-021-05620-y
-
Authors
Murphy, Susan L. https://orcid.org/0000-0001-7924-0012
Lescoat, Alain
Alore, Mary
Hughes, Michael
Pauling, John D.
Sabbagh, Maya
Khanna, Dinesh https://orcid.org/0000-0003-1412-4453
-
Funding
Funding for this research was provided by:
Hôpitaux Universitaire du Grand Ouest (AAP JCM2020)
Rennes University Hospital (CORECT Visiting Grant 2020)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24-AR-063129)
- License Information
-
More Information
Article History
Received: 11 December 2020
Revised: 12 January 2021
Accepted: 17 January 2021
First Online: 24 January 2021
Change Date: 6 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10067-021-05620-y
Compliance with ethical standards
:
: Dr. Pauling reports personal fees from Boehringer Ingelheim; grants, personal fees, and non-financial support from the Actelion Pharmaceuticals; personal fees from Sojournix Pharma, all outside the submitted work. Dr. Hughes reports speakers’ fees from Actelion Pharmaceuticals. Dr. Khanna is a consultant to Acceleron, Abbvie, Actelion, Amgen, Bayer, BMS, Boehringer Ingelheim, CSL Behring, Corbus, Galapagos, Genentech/Roche, GSK, Horizon, MitsubishiTanabe Pharma, Sanofi-Aventis, and United Therapeutics. He has stock options in Eicos Sciences, Inc. No other authors report conflicts of interest or competing interests.
: The study was approved with exempt status by the University of Michigan IRB (Study ID: HUM00175143; OHRP IRB Registration Number(s): IRB00000246).
: N/A
: N/A
: The data underlying this article will be shared on reasonable request to the corresponding author.
: N/A
